MX2015009485A - Uso de la mezcla de una sal y azucar para la fabricacion de un medicamento empleado para tratar el sindrome de vagina laxa o enfermedad de colpoxerosis en un mamifero. - Google Patents
Uso de la mezcla de una sal y azucar para la fabricacion de un medicamento empleado para tratar el sindrome de vagina laxa o enfermedad de colpoxerosis en un mamifero.Info
- Publication number
- MX2015009485A MX2015009485A MX2015009485A MX2015009485A MX2015009485A MX 2015009485 A MX2015009485 A MX 2015009485A MX 2015009485 A MX2015009485 A MX 2015009485A MX 2015009485 A MX2015009485 A MX 2015009485A MX 2015009485 A MX2015009485 A MX 2015009485A
- Authority
- MX
- Mexico
- Prior art keywords
- colpoxerosis disease
- mammal
- sugar
- salt
- manufacture
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 5
- 208000011580 syndromic disease Diseases 0.000 title abstract 3
- 241000124008 Mammalia Species 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 210000001215 vagina Anatomy 0.000 abstract 2
- 238000011587 new zealand white rabbit Methods 0.000 abstract 1
- 210000002460 smooth muscle Anatomy 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se relaciona con un uso de la mezcla de una sal y azúcar en la fabricación de un medicamento empleado para tratar el síndrome de vagina laxa o enfermedad de colpoxerosis en un mamífero. Como se describe en la presente invención, a través de varias pruebas, por ejemplo, prueba de contractilidad del músculo liso vaginal que usa conejo blanco de Nueva Zelanda; (Ejemplo experimental 1); el efecto sobre la contractilidad de la vagina en voluntarias mediante el uso de perinómetro (Ejemplo experimental 2); y el efecto sobre la enfermedad de colpoxerosis en voluntarias (Ejemplo experimental 3), la combinación inventiva mostró efecto de mejora en la contractilidad del tejido de la vagina y enfermedad de colpoxerosis. Por consiguiente, la combinación inventiva puede ser útil en el tratamiento o la prevención del síndrome de vagina laxa o enfermedad de colpoxerosis.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20130117300 | 2013-10-01 | ||
| KR1020140053161A KR101470282B1 (ko) | 2013-10-01 | 2014-05-02 | 소금 및 당의 조합물을 유효성분으로 함유하는 질이완증 또는 질건조증 예방 및 치료용 약학 조성물 및 이의 용도 |
| PCT/KR2014/008180 WO2015050324A1 (en) | 2013-10-01 | 2014-09-02 | A use of the mixture of a salt and sugar in the manufacture of a medicament employed for treating lax vegina syndrome or colpoxerosis disease in a mammal |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015009485A true MX2015009485A (es) | 2015-11-16 |
Family
ID=52678056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015009485A MX2015009485A (es) | 2013-10-01 | 2014-09-02 | Uso de la mezcla de una sal y azucar para la fabricacion de un medicamento empleado para tratar el sindrome de vagina laxa o enfermedad de colpoxerosis en un mamifero. |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US20150342987A1 (es) |
| EP (1) | EP2978435B1 (es) |
| JP (1) | JP6091699B2 (es) |
| KR (1) | KR101470282B1 (es) |
| CN (1) | CN104884070B (es) |
| AU (1) | AU2014330225B2 (es) |
| BR (1) | BR112015015370B1 (es) |
| CA (1) | CA2896936C (es) |
| MX (1) | MX2015009485A (es) |
| MY (1) | MY175936A (es) |
| NZ (1) | NZ709010A (es) |
| PH (1) | PH12015501458B1 (es) |
| RU (1) | RU2613714C2 (es) |
| WO (1) | WO2015050324A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101470282B1 (ko) | 2013-10-01 | 2014-12-05 | 최원석 | 소금 및 당의 조합물을 유효성분으로 함유하는 질이완증 또는 질건조증 예방 및 치료용 약학 조성물 및 이의 용도 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997043989A1 (en) * | 1996-05-22 | 1997-11-27 | Diversified Pharmaceuticals, Inc. | Compositions, methods and devices for the transdermal delivery of drugs |
| KR20010029068A (ko) * | 1999-09-29 | 2001-04-06 | 강권중 | 죽염과 운모를 유효성분으로 함유하는 질정제 |
| CN100389763C (zh) * | 2004-02-10 | 2008-05-28 | 周世兰 | 改善妇女阴道酸、湿性的乳酸、甘油制剂 |
| US20080286384A1 (en) * | 2004-09-15 | 2008-11-20 | Renee Reichert | Topical Wound Care Product Containing Hyssop |
| US7619008B2 (en) * | 2004-11-12 | 2009-11-17 | Kimberly-Clark Worldwide, Inc. | Xylitol for treatment of vaginal infections |
| US8703198B2 (en) * | 2005-03-02 | 2014-04-22 | Aquatrove Biosciences | Water-based personal moisturizers and lubricants, in particular vaginal lubricants, and uses thereof |
| WO2006110024A1 (en) * | 2005-04-11 | 2006-10-19 | R & H Minerals B.V. | Salt product, method for manufacture and use thereof |
| RU2409368C2 (ru) * | 2005-04-27 | 2011-01-20 | Шэньчжэнь Флора Байотекнолоджи Лимитед | Композиция и способ регуляции и поддержания бактериальной микрофлоры и кислотности влагалища |
| CN1994274A (zh) * | 2006-01-04 | 2007-07-11 | 吴天祥 | 仿生精液化妆品 |
| CN101442911A (zh) * | 2006-01-24 | 2009-05-27 | 弗杰尔和弗佐德马特有限公司 | 用于处理肉的、含有糖和盐的组合物 |
| JP2013507328A (ja) * | 2009-10-08 | 2013-03-04 | ツォンミン ツェン， | 有機酸保存剤と組み合わせた安息香酸を活性構成成分として含む組成物、およびその使用 |
| KR101133723B1 (ko) * | 2009-10-19 | 2012-04-09 | 최원석 | 소금 및 당을 유효성분으로 함유하는 질염 예방 및 치료용 조성물 및 이의 용도 |
| RU2428173C1 (ru) * | 2010-06-03 | 2011-09-10 | Общество с ограниченной ответственностью "ЦитоНИР" (ООО "ЦитоНИР") | Фармацевтическая композиция для лечения заболеваний нижнего отдела мочеполовой системы |
| US9078813B2 (en) * | 2010-11-12 | 2015-07-14 | The University Of Utah Research Foundation | Intravaginal devices for controlled delivery of lubricants |
| ES2390033B1 (es) * | 2010-11-30 | 2013-10-31 | Lipotec S.A. | Exopolisacárido para el tratamiento y/o cuidado de la piel, mucosas, cabello y/o uñas. |
| CN102240260B (zh) * | 2011-05-17 | 2012-05-23 | 山东省医疗器械研究所 | 一种治疗阴道干涩症的药物及其制备方法 |
| KR101470282B1 (ko) | 2013-10-01 | 2014-12-05 | 최원석 | 소금 및 당의 조합물을 유효성분으로 함유하는 질이완증 또는 질건조증 예방 및 치료용 약학 조성물 및 이의 용도 |
-
2014
- 2014-05-02 KR KR1020140053161A patent/KR101470282B1/ko active Active
- 2014-09-02 BR BR112015015370-4A patent/BR112015015370B1/pt active IP Right Grant
- 2014-09-02 MY MYPI2015701940A patent/MY175936A/en unknown
- 2014-09-02 NZ NZ709010A patent/NZ709010A/en unknown
- 2014-09-02 US US14/653,853 patent/US20150342987A1/en not_active Abandoned
- 2014-09-02 RU RU2015126018A patent/RU2613714C2/ru active
- 2014-09-02 AU AU2014330225A patent/AU2014330225B2/en active Active
- 2014-09-02 WO PCT/KR2014/008180 patent/WO2015050324A1/en active Application Filing
- 2014-09-02 JP JP2016505420A patent/JP6091699B2/ja active Active
- 2014-09-02 EP EP14850829.4A patent/EP2978435B1/en active Active
- 2014-09-02 CN CN201480004031.2A patent/CN104884070B/zh active Active
- 2014-09-02 MX MX2015009485A patent/MX2015009485A/es active IP Right Grant
- 2014-09-02 CA CA2896936A patent/CA2896936C/en active Active
-
2015
- 2015-06-24 PH PH12015501458A patent/PH12015501458B1/en unknown
-
2016
- 2016-09-11 US US15/262,000 patent/US9827267B2/en active Active
-
2017
- 2017-08-29 US US15/688,871 patent/US9925216B2/en active Active
- 2017-08-29 US US15/688,872 patent/US9867850B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR101470282B1 (ko) | 2014-12-05 |
| PH12015501458A1 (en) | 2015-09-21 |
| JP2016515574A (ja) | 2016-05-30 |
| BR112015015370B1 (pt) | 2020-11-10 |
| CN104884070B (zh) | 2016-08-31 |
| NZ709010A (en) | 2017-05-26 |
| EP2978435A1 (en) | 2016-02-03 |
| JP6091699B2 (ja) | 2017-03-08 |
| US9827267B2 (en) | 2017-11-28 |
| CA2896936C (en) | 2018-03-06 |
| AU2014330225B2 (en) | 2016-11-17 |
| MY175936A (en) | 2020-07-15 |
| HK1210412A1 (zh) | 2016-04-22 |
| EP2978435A4 (en) | 2017-01-04 |
| RU2613714C2 (ru) | 2017-03-21 |
| WO2015050324A1 (en) | 2015-04-09 |
| RU2015126018A (ru) | 2017-01-10 |
| US20170354679A1 (en) | 2017-12-14 |
| US20160375053A1 (en) | 2016-12-29 |
| US20150342987A1 (en) | 2015-12-03 |
| PH12015501458B1 (en) | 2015-09-21 |
| US9925216B2 (en) | 2018-03-27 |
| CA2896936A1 (en) | 2015-04-09 |
| US20170354678A1 (en) | 2017-12-14 |
| CN104884070A (zh) | 2015-09-02 |
| AU2014330225A1 (en) | 2015-07-02 |
| BR112015015370A2 (pt) | 2017-07-11 |
| US9867850B2 (en) | 2018-01-16 |
| EP2978435B1 (en) | 2019-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1121076T1 (el) | Τρικυκλικες ενωσεις ως αντικαρκινικοι παραγοντες | |
| MX2024010140A (es) | Nuevos metodos. | |
| PH12016500105A1 (en) | Sulfonamides as modulators of sodium channels | |
| EA201591591A1 (ru) | Соединения карбазола, применяемые в качестве ингибиторов бромодомена | |
| IN2015DN01156A (es) | ||
| MX2013012253A (es) | Conjugados novedosos de aglutinante-farmaco (adc) y su uso. | |
| EA201790202A1 (ru) | Фталазиноны и изохинолиноны в качестве ингибиторов rock | |
| MX380273B (es) | Conjugados de farmacos anticuerpo (adcs) con inhibidores de ksp. | |
| MX365294B (es) | Inhibidores de proteína cinasa dependiente de adn. | |
| WO2014179564A8 (en) | Thiazolopyrrolidine inhibitors of ror-gamma | |
| EA201690964A1 (ru) | Композиции и способы для уменьшения серьезных неблагоприятных сердечно-сосудистых явлений | |
| EA201591363A1 (ru) | Аналоги тиадиазола и способы лечения состояний, связанных с дефицитом smn | |
| EA201501032A1 (ru) | Фармацевтическая композиция, способы лечения и ее применения | |
| GT201600002A (es) | Bencil-1h-pirazolo[3,4-b]piridinas y su uso | |
| BR112015029386A8 (pt) | uso de eribulina e lenvatinibe como terapia de combinação, composição farmacêutica compreendendo os mesmos e kit | |
| EA201690657A1 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ 3-(1H-ПИРАЗОЛ-4-ИЛ)-1H-ПИРРОЛО[2,3-c]ПИРИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ NIK | |
| EA201500851A1 (ru) | ЭСТРА-1,3,5(10),16-ТЕТРАЕН-3-КАРБОКСАМИДЫ ДЛЯ ИНГИБИРОВАНИЯ 17β-ГИДРОКСИСТЕРОИД-ДЕГИДРОГЕНАЗЫ (AKR1C3) | |
| UY35693A (es) | Pirazolo[1,5-a]piridin-3-carboxamidas sustituidas y su uso | |
| MX2016003861A (es) | Nuevos derivados de 1-(4-pirimidinil)-1h-pirrolo[3,2-c]piridina como inhibidores de la cinasa inductora de nf-kappab. | |
| EA201591618A1 (ru) | Замещенные имидазопиридазины | |
| CA2929436C (en) | Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases | |
| UA117032C2 (uk) | Селективний інгібітор фосфатидилінозитол-3-кінази-гамма | |
| EA201600398A1 (ru) | Тиенопиримидины в качестве ингибиторов mknk1 и mknk2 | |
| MX357888B (es) | Sales basicas de adicion de nitroxolina y usos de las mismas. | |
| MX384303B (es) | Composiciones y métodos para metabolismo muscular mejorado. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |